English

Celator Pharmaceuticals Inc

EDGAR

CELPHAP Quarterly report (10-Q) · filed 2016-05-10

17 filing records in this dataset, filed from 2013-04-01 to 2016-05-10. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 67.5 million USD 2016-03-31 Source
Exact value

67541467 USD
Long-term debt including current maturities: 13.3 million USD 2016-03-31 Source
Exact value

13274500 USD
Shares outstanding: 41.2 million shares 2016-03-31 Source
Exact value

41222270 shares

Reported share-count change

22.17% · 7.48 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

33741872 shares · 2015-03-31· Source
41222270 shares · 2016-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-20.1 million USD

2015-04-01 – 2016-03-31

Exact inputs and evidence

Net income: -4981526 USD · 2015-04-01 – 2015-06-30 Source
Net income: -5210291 USD · 2015-07-01 – 2015-09-30 Source
Net income: -19315348 USD · 2015-01-01 – 2015-12-31 Source
Net income: -14902800 USD · 2015-01-01 – 2015-09-30 Source
Net income: -5533323 USD · 2016-01-01 – 2016-03-31 Source

Operating cash flow

-16.1 million USD

2015-04-01 – 2016-03-31

Exact inputs and evidence

Operating cash flow: -9011545 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -4494202 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -13319820 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -9011545 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -15490209 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -13319820 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -5105662 USD · 2016-01-01 – 2016-03-31 Source

Capital expenditure

40.7 thousand USD

2015-04-01 – 2016-03-31

Exact inputs and evidence

Capital expenditure: 34128 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 17938 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 44487 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 34128 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 55360 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 44487 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 3295 USD · 2016-01-01 – 2016-03-31 Source

Free cash flow

-16.1 million USD

2015-04-01 – 2016-03-31

Exact inputs and evidence

Operating cash flow: -9011545 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -4494202 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -13319820 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -9011545 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -15490209 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -13319820 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -5105662 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 34128 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 17938 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 44487 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 34128 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 55360 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 44487 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 3295 USD · 2016-01-01 – 2016-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-05-10.

Financial data available through: 2015-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 5 of 11 periods available· newest 2015-12-31
Net income: 11 of 11 periods available· newest 2015-12-31
Operating cash flow: 5 of 11 periods available· newest 2015-12-31
Capital expenditure: 5 of 11 periods available· newest 2015-12-31
Total assets: 5 of 11 periods available· newest 2015-12-31
Total liabilities: 5 of 11 periods available· newest 2015-12-31
Current assets: 5 of 11 periods available· newest 2015-12-31
Current liabilities: 5 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2015-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2015-12-31
Shares outstanding: 5 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 2.41 million

Prior period

−USD 16.9 million

2014-01-01 – 2014-12-31
Current period

−USD 19.32 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-19315348 − -16902883 = -2412465 USD

-16902883 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-19315348 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Celator Pharmaceuticals Inc · 2015-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Year-over-year change in Net income: -2412465 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -19315348 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#98749 Filing: 000114420416089052 Input fundies:NetIncome: -16902883 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#98888 Filing: 000114420416089052
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 1.08 million

Prior period

−USD 14.41 million

2014-01-01 – 2014-12-31
Current period

−USD 15.49 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-15490209 − -14411996 = -1078213 USD

-14411996 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-15490209 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Celator Pharmaceuticals Inc · 2015-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Year-over-year change in Operating cash flow: -1078213 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -15490209 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#120072 Filing: 000114420416089052 Input fundies:OperatingCashFlow: -14411996 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#119834 Filing: 000114420416089052
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-14.7%

Prior period

USD 64,865

2014-01-01 – 2014-12-31
Current period

USD 55,360

2015-01-01 – 2015-12-31

Exact inputs and evidence

55360 − 64865 = -9505 USD

64865 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
55360 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Celator Pharmaceuticals Inc · 2015-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Year-over-year change in Capital expenditure: -9505 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 55360 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#120504 Filing: 000114420416089052 Input fundies:CapitalExpenditure: 64865 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#120310 Filing: 000114420416089052
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2006-01-01 – 2006-12-31	−USD 14.59 million Exact value Exact value: -14588786 USD 2006-01-01 – 2006-12-31: -14588786 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celator Pharmaceuticals Inc · 2006-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Net Income: -14588786 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14588786 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420414017335/cpxx-20131231.xml#681672 Filing: 000114420414017335 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 16.76 million Exact value Exact value: -16761805 USD 2007-01-01 – 2007-12-31: -16761805 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celator Pharmaceuticals Inc · 2007-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Net Income: -16761805 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16761805 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420414017335/cpxx-20131231.xml#682979 Filing: 000114420414017335 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 14.03 million Exact value Exact value: -14028617 USD 2008-01-01 – 2008-12-31: -14028617 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celator Pharmaceuticals Inc · 2008-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Net Income: -14028617 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14028617 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420414017335/cpxx-20131231.xml#684286 Filing: 000114420414017335 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	−USD 10.02 million Exact value Exact value: -10022979 USD 2009-01-01 – 2009-12-31: -10022979 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celator Pharmaceuticals Inc · 2009-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Net Income: -10022979 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10022979 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420414017335/cpxx-20131231.xml#685593 Filing: 000114420414017335 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 10.81 million Exact value Exact value: -10814788 USD 2010-01-01 – 2010-12-31: -10814788 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celator Pharmaceuticals Inc · 2010-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Net Income: -10814788 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10814788 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420414017335/cpxx-20131231.xml#686900 Filing: 000114420414017335 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2011 2011-01-01 – 2011-12-31	−USD 14.16 million Exact value Exact value: -14159754 USD 2011-01-01 – 2011-12-31: -14159754 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celator Pharmaceuticals Inc · 2011-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Net Income: -14159754 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14159754 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420414017335/cpxx-20131231.xml#688207 Filing: 000114420414017335 The citation records this snapshot. The page link may show a newer release later.	−USD 14.6 million Exact value Exact value: -14600244 USD 2011-01-01 – 2011-12-31: -14600244 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Celator Pharmaceuticals Inc · 2011-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Operating Cash Flow: -14600244 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14600244 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000119312513242720/celphap-20130331.xml#318666 Filing: 000119312513242720 The citation records this snapshot. The page link may show a newer release later.	USD 380,299 Exact value Exact value: 380299 USD 2011-01-01 – 2011-12-31: 380299 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Celator Pharmaceuticals Inc · 2011-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Capital Expenditure: 380299 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 380299 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000119312513242720/celphap-20130331.xml#314006 Filing: 000119312513242720 The citation records this snapshot. The page link may show a newer release later.	−USD 14.98 million Calculation and evidence -14600244 − 380299 USD Exact free cash flow: -14980543 USD 2011-01-01 – 2011-12-31: -14600244 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 380299 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Celator Pharmaceuticals Inc · 2011-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Free cash flow: -14980543 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14600244 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000119312513242720/celphap-20130331.xml#318666 Filing: 000119312513242720 Input fundies:CapitalExpenditure: 380299 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000119312513242720/celphap-20130331.xml#314006 Filing: 000119312513242720 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 10.91 million Exact value Exact value: -10908727 USD 2012-01-01 – 2012-12-31: -10908727 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celator Pharmaceuticals Inc · 2012-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Net Income: -10908727 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10908727 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420414017335/cpxx-20131231.xml#532992 Filing: 000114420414017335 The citation records this snapshot. The page link may show a newer release later.	−USD 4.97 million Exact value Exact value: -4968207 USD 2012-01-01 – 2012-12-31: -4968207 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Celator Pharmaceuticals Inc · 2012-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Operating Cash Flow: -4968207 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4968207 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420414017335/cpxx-20131231.xml#714047 Filing: 000114420414017335 The citation records this snapshot. The page link may show a newer release later.	USD 35,752 Exact value Exact value: 35752 USD 2012-01-01 – 2012-12-31: 35752 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Celator Pharmaceuticals Inc · 2012-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Capital Expenditure: 35752 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 35752 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420414017335/cpxx-20131231.xml#716503 Filing: 000114420414017335 The citation records this snapshot. The page link may show a newer release later.	−USD 5 million Calculation and evidence -4968207 − 35752 USD Exact free cash flow: -5003959 USD 2012-01-01 – 2012-12-31: -4968207 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 35752 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Celator Pharmaceuticals Inc · 2012-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Free cash flow: -5003959 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4968207 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420414017335/cpxx-20131231.xml#714047 Filing: 000114420414017335 Input fundies:CapitalExpenditure: 35752 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420414017335/cpxx-20131231.xml#716503 Filing: 000114420414017335 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 20.84 million Exact value Exact value: -20844155 USD 2013-01-01 – 2013-12-31: -20844155 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celator Pharmaceuticals Inc · 2013-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Net Income: -20844155 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20844155 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420415016717/cpxx-20141231.xml#475460 Filing: 000114420415016717 The citation records this snapshot. The page link may show a newer release later.	−USD 12.46 million Exact value Exact value: -12459651 USD 2013-01-01 – 2013-12-31: -12459651 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Celator Pharmaceuticals Inc · 2013-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Operating Cash Flow: -12459651 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12459651 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420415016717/cpxx-20141231.xml#515773 Filing: 000114420415016717 The citation records this snapshot. The page link may show a newer release later.	USD 92,523 Exact value Exact value: 92523 USD 2013-01-01 – 2013-12-31: 92523 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Celator Pharmaceuticals Inc · 2013-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Capital Expenditure: 92523 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 92523 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420415016717/cpxx-20141231.xml#516249 Filing: 000114420415016717 The citation records this snapshot. The page link may show a newer release later.	−USD 12.55 million Calculation and evidence -12459651 − 92523 USD Exact free cash flow: -12552174 USD 2013-01-01 – 2013-12-31: -12459651 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 92523 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Celator Pharmaceuticals Inc · 2013-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Free cash flow: -12552174 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12459651 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420415016717/cpxx-20141231.xml#515773 Filing: 000114420415016717 Input fundies:CapitalExpenditure: 92523 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420415016717/cpxx-20141231.xml#516249 Filing: 000114420415016717 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 16.9 million Exact value Exact value: -16902883 USD 2014-01-01 – 2014-12-31: -16902883 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celator Pharmaceuticals Inc · 2014-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Net Income: -16902883 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16902883 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#98888 Filing: 000114420416089052 The citation records this snapshot. The page link may show a newer release later.	−USD 14.41 million Exact value Exact value: -14411996 USD 2014-01-01 – 2014-12-31: -14411996 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Celator Pharmaceuticals Inc · 2014-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Operating Cash Flow: -14411996 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14411996 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#119834 Filing: 000114420416089052 The citation records this snapshot. The page link may show a newer release later.	USD 64,865 Exact value Exact value: 64865 USD 2014-01-01 – 2014-12-31: 64865 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Celator Pharmaceuticals Inc · 2014-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Capital Expenditure: 64865 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 64865 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#120310 Filing: 000114420416089052 The citation records this snapshot. The page link may show a newer release later.	−USD 14.48 million Calculation and evidence -14411996 − 64865 USD Exact free cash flow: -14476861 USD 2014-01-01 – 2014-12-31: -14411996 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 64865 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Celator Pharmaceuticals Inc · 2014-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Free cash flow: -14476861 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14411996 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#119834 Filing: 000114420416089052 Input fundies:CapitalExpenditure: 64865 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#120310 Filing: 000114420416089052 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 19.32 million Exact value Exact value: -19315348 USD 2015-01-01 – 2015-12-31: -19315348 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celator Pharmaceuticals Inc · 2015-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Net Income: -19315348 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19315348 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#98749 Filing: 000114420416089052 The citation records this snapshot. The page link may show a newer release later.	−USD 15.49 million Exact value Exact value: -15490209 USD 2015-01-01 – 2015-12-31: -15490209 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Celator Pharmaceuticals Inc · 2015-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Operating Cash Flow: -15490209 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15490209 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#120072 Filing: 000114420416089052 The citation records this snapshot. The page link may show a newer release later.	USD 55,360 Exact value Exact value: 55360 USD 2015-01-01 – 2015-12-31: 55360 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Celator Pharmaceuticals Inc · 2015-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Capital Expenditure: 55360 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 55360 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#120504 Filing: 000114420416089052 The citation records this snapshot. The page link may show a newer release later.	−USD 15.55 million Calculation and evidence -15490209 − 55360 USD Exact free cash flow: -15545569 USD 2015-01-01 – 2015-12-31: -15490209 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 55360 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Celator Pharmaceuticals Inc · 2015-12-31 Celator Pharmaceuticals Inc (edgar:1327467) Free cash flow: -15545569 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-06T02:47:10Z Snapshot: 1f106ff2cdad415c8897e23e0e0495893187a0ec6cbc84676f5e91a0ffacf4c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1327467?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15490209 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#120072 Filing: 000114420416089052 Input fundies:CapitalExpenditure: 55360 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1327467/000114420416089052/cpxx-20151231.xml#120504 Filing: 000114420416089052 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

17 filings · 895 latest values · 895 originally reported values

Dataset published 2026-11-06. Source filing dates and reporting periods are shown separately.

Identifiers: 0001327467, 1327467, CELPHAP, CPXX, edgar:1327467

Also known as Celator Pharmaceuticals Inc

Celator Pharmaceuticals Inc

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation